Mainstream

Astra plans full new york listing in blow to london: move fuels fears pharma giant could abandon uk altogether

Astra plans full New York listing in blow to London: Move fuels fears pharma giant could abandon UK altogether

Astra plans full New York listing in blow to London: Move fuels fears pharma giant could abandon UK altogether

The move beefs up the £170bn pharma group’s presence in the US, in a move designed to help it ‘reach a broader mix of global investors’.Read More

You might also be interested in reading Green Bitcoin: Sustainable Energy Usage Surges To Record 55% High.

September 29, 2025
In Mainstream